JOEL SAGET/AFP via Getty ImagesOfficials in Europe are investigating the possible risk of peo...

JOEL SAGET/AFP via Getty ImagesOfficials in Europe are investigating the possible risk of people on Ozempic developing suicidal thoughts. Suicidal thoughts or thoughts of self-harm are not listed as possible side effects in the EMA product information for either Ozempic or Saxenda.These drugs stimulate the release of insulin after someone eats, which can help lower blood sugar levels. They are also associated with weight loss.The European Medicines Agencyҳ safety committee is investigating a possible risk of suicidal thoughts and thoughts of self-harm from certain drugs used to treat obesity and diabetes, according to a statement July 11.Review includes popular U.S. diabetes drug The investigation comes after the Icelandic Medicines Agency identified two cases of suicidal thoughts, one after use of Ozempic and another following use of Saxenda. Another case involved thoughts of self-harm after use of Saxenda.Ozempic, which contains semaglutide, is approved in the United States by the Food and Drug Administration as a treatment for type 2 diabetes. Semaglutide is also approved by the FDA under the brand name Wegovy as a treatment for obesity.Saxenda, which contains the active ingredient liraglutide, is used to treat obesity. All three drugs are made by Danish firm Novo Nordisk.Ӕhe review is being carried out in the context of a signal procedure. A signal is information on a new adverse event that is potentially caused by a medicine or a new aspect of a known adverse event that warrants further investigation,Ԡthe EMA said in a statement. Ӕhe presence of a signal does...Continue reading